SEC Form 4 · accession 0001478916-26-000015
BlossomHill Therapeutics, Inc. · BLSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P. Schmid
Director
Period of report
Aug 10, 2026
Accepted (ET)
Aug 10, 2026 · 6:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001839970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2026 | P | 6,000 | $16.00 | A | 6,000 | D |
Table II — derivative securities
No Table II lines on this filing.